LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 365

Search options

  1. Article ; Online: Rapid Detection of the Omicron (B.1.1.529) SARS-CoV-2 Variant Using a COVID-19 Diagnostic PCR Assay.

    Ippoliti, Chiara / De Maio, Flavio / Santarelli, Giulia / Marchetti, Simona / Vella, Antonietta / Santangelo, Rosaria / Sanguinetti, Maurizio / Posteraro, Brunella

    Microbiology spectrum

    2022  Volume 10, Issue 4, Page(s) e0099022

    Abstract: The Omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is ...

    Abstract The Omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the last variant of concern (VOC) identified to date. Compared to whole-genome or gene-specific sequencing methods, reverse-transcription PCR assays may be a simpler approach to study VOCs. We used a point-of-care COVID-19 diagnostic PCR assay to detect the Omicron SARS-CoV-2 variant in the respiratory tract samples of COVID-19 patients who had tested positive for SARS-CoV-2 RNA between April 2021 and January 2022. Sequencing analyses had shown that 87 samples were positive for the Omicron variant and 43 samples were positive for a non-Omicron variant (Delta, 18 samples; Alpha, 13 samples; Gamma, 10 samples; Beta, 1 sample; or Epsilon, 1 sample). According to results by the PCR assay, whose primers anneal a nucleocapsid (N) gene region that comprises the E31/R32/S33 deletion (also termed the del31/33 mutation), we found that N gene target failure/dropout (i.e., a negative/low result) occurred in 86 (98.8%) of 87 Omicron variant-positive samples tested. These results were assessed in relation to those of the spike (S) gene, which expectedly, was detected in all (100%) 130 samples. A total of 43 (100%) of 43 Delta, Alpha, Gamma, Beta, or Epsilon variant-positive samples had a positive result with the N gene. Importantly, in 86 of 87 Omicron variant-positive samples, the del31/33 mutation was detected together with a P13L mutation, which was, instead, detected alone in the Omicron variant-positive sample that had a positive N-gene result.
    MeSH term(s) COVID-19/diagnosis ; COVID-19 Testing ; Humans ; Mutation ; Polymerase Chain Reaction ; RNA, Viral/analysis ; RNA, Viral/genetics ; SARS-CoV-2/genetics ; Sensitivity and Specificity
    Chemical Substances RNA, Viral
    Language English
    Publishing date 2022-07-05
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2807133-5
    ISSN 2165-0497 ; 2165-0497
    ISSN (online) 2165-0497
    ISSN 2165-0497
    DOI 10.1128/spectrum.00990-22
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Retroperitoneal fibrosis due to B-cell non-Hodgkin lymphoma: Responding to rituximab!

    Alvarez Argote, Juliana / Bauer, Frank A / Posteraro, Anthony F / Dasanu, Constantin A

    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

    2016  Volume 22, Issue 1, Page(s) 179–185

    Abstract: ... hydronephrosis and renal failure, in whom, after a complex diagnostic work-up and protracted clinical course, a B ...

    Abstract Retroperitoneal fibrosis is a rare disease manifesting as chronic soft tissue fibrosis in the retroperitoneum, with potential anatomic and/or functional compromise of adjacent organs. It can be primary (idiopathic) or secondary to other conditions such as cancers, autoimmune disorders, or drugs. We report herein a 66-year-old patient with symptomatic retroperitoneal fibrosis leading to bilateral hydronephrosis and renal failure, in whom, after a complex diagnostic work-up and protracted clinical course, a B-cell non-Hodgkin lymphoma in the retroperitoneal space and several vertebral bodies was identified. The patient was treated with radiation therapy and weekly rituximab infusions, with resolution of hydronephrosis and lower back pain. We include a thorough literature review on etiopathogenesis, diagnosis, therapy, and prognosis of retroperitoneal fibrosis. A meticulous search for malignancy is necessary in this rare condition that, if positive, may have significant therapeutic and prognostic implications.
    MeSH term(s) Aged ; Antineoplastic Agents/therapeutic use ; B-Lymphocytes/drug effects ; B-Lymphocytes/pathology ; Female ; Humans ; Lymphoma, Non-Hodgkin/drug therapy ; Lymphoma, Non-Hodgkin/pathology ; Retroperitoneal Fibrosis/drug therapy ; Retroperitoneal Fibrosis/pathology ; Rituximab/therapeutic use
    Chemical Substances Antineoplastic Agents ; Rituximab (4F4X42SYQ6)
    Language English
    Publishing date 2016-02
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 1330764-2
    ISSN 1477-092X ; 1078-1552
    ISSN (online) 1477-092X
    ISSN 1078-1552
    DOI 10.1177/1078155214543279
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: In vitro interaction between alginate lyase and amphotericin B against Aspergillus fumigatus biofilm determined by different methods.

    Bugli, Francesca / Posteraro, Brunella / Papi, Massimiliano / Torelli, Riccardo / Maiorana, Alessandro / Paroni Sterbini, Francesco / Posteraro, Patrizia / Sanguinetti, Maurizio / De Spirito, Marco

    Antimicrobial agents and chemotherapy

    2012  Volume 57, Issue 3, Page(s) 1275–1282

    Abstract: ... the most difficult-to-treat Aspergillus-related disease. While the antibiofilm activities of amphotericin B ...

    Abstract Aspergillus fumigatus biofilms represent a problematic clinical entity, especially because of their recalcitrance to antifungal drugs, which poses a number of therapeutic implications for invasive aspergillosis, the most difficult-to-treat Aspergillus-related disease. While the antibiofilm activities of amphotericin B (AMB) deoxycholate and its lipid formulations (e.g., liposomal AMB [LAMB]) are well documented, the effectiveness of these drugs in combination with nonantifungal agents is poorly understood. In the present study, in vitro interactions between polyene antifungals (AMB and LAMB) and alginate lyase (AlgL), an enzyme degrading the polysaccharides produced as extracellular polymeric substances (EPSs) within the biofilm matrix, against A. fumigatus biofilms were evaluated by using the checkerboard microdilution and the time-kill assays. Furthermore, atomic force microscopy (AFM) was used to image and quantify the effects of AlgL-antifungal combinations on biofilm-growing hyphal cells. On the basis of fractional inhibitory concentration index values, synergy was found between both AMB formulations and AlgL, and this finding was also confirmed by the time-kill test. Finally, AFM analysis showed that when A. fumigatus biofilms were treated with AlgL or polyene alone, as well as with their combination, both a reduction of hyphal thicknesses and an increase of adhesive forces were observed compared to the findings for untreated controls, probably owing to the different action by the enzyme or the antifungal compounds. Interestingly, marked physical changes were noticed in A. fumigatus biofilms exposed to the AlgL-antifungal combinations compared with the physical characteristics detected after exposure to the antifungals alone, indicating that AlgL may enhance the antibiofilm activity of both AMB and LAMB, perhaps by disrupting the hypha-embedding EPSs and thus facilitating the drugs to reach biofilm cells. Taken together, our results suggest that a combination of AlgL and a polyene antifungal may prove to be a new therapeutic strategy for invasive aspergillosis, while reinforcing the EPS as a valuable antibiofilm drug target.
    MeSH term(s) Amphotericin B/pharmacology ; Antifungal Agents/pharmacology ; Aspergillus fumigatus/drug effects ; Aspergillus fumigatus/growth & development ; Aspergillus fumigatus/ultrastructure ; Bacterial Proteins/pharmacology ; Biofilms/drug effects ; Biofilms/growth & development ; Deoxycholic Acid/pharmacology ; Drug Combinations ; Drug Synergism ; Fungal Polysaccharides/metabolism ; Hyphae/drug effects ; Hyphae/growth & development ; Hyphae/ultrastructure ; Microbial Sensitivity Tests ; Microscopy, Atomic Force ; Polysaccharide-Lyases/pharmacology
    Chemical Substances Antifungal Agents ; Bacterial Proteins ; Drug Combinations ; Fungal Polysaccharides ; liposomal amphotericin B ; Deoxycholic Acid (005990WHZZ) ; Amphotericin B (7XU7A7DROE) ; amphotericin B, deoxycholate drug combination (87687-70-5) ; Polysaccharide-Lyases (EC 4.2.2.-) ; poly(beta-D-mannuronate) lyase (EC 4.2.2.3)
    Language English
    Publishing date 2012-12-21
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 217602-6
    ISSN 1098-6596 ; 0066-4804
    ISSN (online) 1098-6596
    ISSN 0066-4804
    DOI 10.1128/AAC.01875-12
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies.

    Colozza, Camilla / Posteraro, Brunella / Santilli, Stefania / De Carolis, Elena / Sanguinetti, Maurizio / Girmenia, Corrado

    International journal of antimicrobial agents

    2012  Volume 39, Issue 5, Page(s) 440–443

    Abstract: Although there is evidence that liposomal amphotericin B (AmBisome) is non-inferior to amphotericin ... B (AmB) in terms of in vivo efficacy, in vitro data regarding the activity of AmBisome against ...

    Abstract Although there is evidence that liposomal amphotericin B (AmBisome) is non-inferior to amphotericin B (AmB) in terms of in vivo efficacy, in vitro data regarding the activity of AmBisome against clinical isolates of Aspergillus are rare. In this study, the susceptibilities to AmB and AmBisome of 103 Aspergillus complex isolates (48 Aspergillus flavus, 33 Aspergillus fumigatus, 13 Aspergillus terreus and 9 Aspergillus niger) recovered from haematological patients with invasive infection were compared. Minimum inhibitory concentrations (MICs) were determined by the broth microdilution (BMD) method according to the Clinical and Laboratory Standards Institute (CLSI), whilst AmB susceptibility was also determined by Etest. Using a susceptible/resistant MIC cut-off of 1mg/L, all A. fumigatus and A. niger complexes isolates were susceptible to both AmB and AmBisome. In contrast, 38.5% and 30.8% of the A. terreus complex isolates were resistant to AmB and AmBisome, respectively, with good agreement between BMD and Etest methods. With respect to A. flavus complex isolates, 43.7% and 16.7% were resistant by the BMD method to AmBisome and AmB, respectively. For isolates with discrepant results, AmB MICs obtained by Etest were higher than those obtained for AmB by the BMD method and they were closer to those obtained for AmBisome by BMD. Aspergillus flavus AmB MICs ranged from 0.5 mg/L to 2 mg/L by the BMD method and from 1 mg/L to >16 mg/L by the Etest method, and AmBisome MICs ranged from 0.06 mg/L to >16 mg/L by the BMD method. Etest appears to be superior to the CLSI BMD method using AmB in detecting AmB resistance of Aspergillus spp., although the CLSI BMD method might be a suitable procedure if AmBisome is used as the test drug.
    MeSH term(s) Amphotericin B/pharmacology ; Antifungal Agents/pharmacology ; Aspergillosis/microbiology ; Aspergillus/drug effects ; Aspergillus/isolation & purification ; Drug Resistance, Fungal ; Hematologic Neoplasms/complications ; Humans ; Italy ; Microbial Sensitivity Tests
    Chemical Substances Antifungal Agents ; Amphotericin B (7XU7A7DROE)
    Language English
    Publishing date 2012-05
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1093977-5
    ISSN 1872-7913 ; 0924-8579
    ISSN (online) 1872-7913
    ISSN 0924-8579
    DOI 10.1016/j.ijantimicag.2012.01.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Role of methionine sulfoxide reductases A and B of Enterococcus faecalis in oxidative stress and virulence.

    Zhao, Chen / Hartke, Axel / La Sorda, Marilena / Posteraro, Brunella / Laplace, Jean-Marie / Auffray, Yanick / Sanguinetti, Maurizio

    Infection and immunity

    2010  Volume 78, Issue 9, Page(s) 3889–3897

    Abstract: Methionine sulfoxide reductases A and B are antioxidant repair enzymes that reduce the S- and R ...

    Abstract Methionine sulfoxide reductases A and B are antioxidant repair enzymes that reduce the S- and R-diastereomers of methionine sulfoxides back to methionine, respectively. Enterococcus faecalis, an important nosocomial pathogen, has one msrA gene and one msrB gene situated in different parts of the chromosome. Promoters have been mapped and mutants have been constructed in two E. faecalis strains (strains JH2-2 and V583) and characterized. For both backgrounds, the mutants are more sensitive than the wild-type parents to exposure to H2O2, and in combination the mutations seem to be additive. The virulence of the mutants has been analyzed in four different models. Survival of the mutants inside mouse peritoneal macrophages stimulated with recombinant gamma interferon plus lipopolysaccharide but not in naïve phagocytes is significantly affected. The msrA mutant is attenuated in the Galleria mellonella insect model. Deficiency in either Msr enzyme reduced the level of virulence in a systemic and urinary tract infection model. Virulence was reconstituted in the complemented strains. The combined results show that Msr repair enzymes are important for the oxidative stress response, macrophage survival, and persistent infection with E. faecalis.
    MeSH term(s) Animals ; Enterococcus faecalis/genetics ; Enterococcus faecalis/metabolism ; Enterococcus faecalis/pathogenicity ; Female ; Methionine Sulfoxide Reductases/genetics ; Methionine Sulfoxide Reductases/physiology ; Mice ; Mice, Inbred BALB C ; Operon ; Oxidative Stress ; Promoter Regions, Genetic ; Virulence
    Chemical Substances Methionine Sulfoxide Reductases (EC 1.8.4.-) ; methionine sulfoxide reductase (EC 1.8.4.11)
    Language English
    Publishing date 2010-06-21
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 218698-6
    ISSN 1098-5522 ; 0019-9567
    ISSN (online) 1098-5522
    ISSN 0019-9567
    DOI 10.1128/IAI.00165-10
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: In-depth characterization of multidrug-resistant NDM-1 and KPC-3 co-producing

    Posteraro, Brunella / De Maio, Flavio / Motro, Yair / Menchinelli, Giulia / De Lorenzis, Desy / Marano, Roberto B M / Aljanazreh, Bessan / Errico, Federica Maria / Massaria, Giuseppe / Spanu, Teresa / Posteraro, Patrizia / Moran-Gilad, Jacob / Sanguinetti, Maurizio

    Microbiology spectrum

    2024  Volume 12, Issue 4, Page(s) e0330523

    Abstract: Bloodstream infection (BSI) caused by carbapenem- ... ...

    Abstract Bloodstream infection (BSI) caused by carbapenem-resistant
    MeSH term(s) Humans ; Klebsiella pneumoniae ; Colistin ; Phylogeny ; Klebsiella Infections/epidemiology ; Multilocus Sequence Typing ; beta-Lactamases/genetics ; Bacterial Proteins/genetics ; Anti-Bacterial Agents/pharmacology ; Carbapenems ; Anti-Infective Agents ; Plasmids/genetics ; Italy ; Hospitals ; Microbial Sensitivity Tests
    Chemical Substances Colistin (Z67X93HJG1) ; beta-Lactamases (EC 3.5.2.6) ; Bacterial Proteins ; Anti-Bacterial Agents ; Carbapenems ; Anti-Infective Agents
    Language English
    Publishing date 2024-02-27
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2807133-5
    ISSN 2165-0497 ; 2165-0497
    ISSN (online) 2165-0497
    ISSN 2165-0497
    DOI 10.1128/spectrum.03305-23
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Setting-specific variability of false-positive result rates with rapid testing for SARS-CoV-2 antigen.

    Posteraro, Patrizia / Errico, Federica Maria / De Carolis, Antonella / Menchinelli, Giulia / Sanguinetti, Maurizio / Posteraro, Brunella

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

    2022  Volume 149, Page(s) 105132

    MeSH term(s) Antigens, Viral ; COVID-19/diagnosis ; COVID-19 Serological Testing ; Humans ; Immunologic Tests ; SARS-CoV-2 ; Sensitivity and Specificity
    Chemical Substances Antigens, Viral
    Language English
    Publishing date 2022-03-14
    Publishing country Netherlands
    Document type Letter
    ZDB-ID 1446080-4
    ISSN 1873-5967 ; 1386-6532
    ISSN (online) 1873-5967
    ISSN 1386-6532
    DOI 10.1016/j.jcv.2022.105132
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Old and New Insights into

    De Carolis, Elena / Posteraro, Brunella / Sanguinetti, Maurizio

    Pathogens (Basel, Switzerland)

    2022  Volume 11, Issue 3

    Abstract: Sporothrix ... ...

    Abstract Sporothrix schenckii
    Language English
    Publishing date 2022-02-25
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2695572-6
    ISSN 2076-0817
    ISSN 2076-0817
    DOI 10.3390/pathogens11030297
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies

    Colozza, Camilla / Posteraro, Brunella / Santilli, Stefania / De Carolis, Elena / Sanguinetti, Maurizio / Girmenia, Corrado

    International journal of antimicrobial agents. 2012 May, v. 39, no. 5

    2012  

    Abstract: Although there is evidence that liposomal amphotericin B (AmBisome) is non-inferior to amphotericin ... B (AmB) in terms of in vivo efficacy, in vitro data regarding the activity of AmBisome against ...

    Abstract Although there is evidence that liposomal amphotericin B (AmBisome) is non-inferior to amphotericin B (AmB) in terms of in vivo efficacy, in vitro data regarding the activity of AmBisome against clinical isolates of Aspergillus are rare. In this study, the susceptibilities to AmB and AmBisome of 103 Aspergillus complex isolates (48 Aspergillus flavus, 33 Aspergillus fumigatus, 13 Aspergillus terreus and 9 Aspergillus niger) recovered from haematological patients with invasive infection were compared. Minimum inhibitory concentrations (MICs) were determined by the broth microdilution (BMD) method according to the Clinical and Laboratory Standards Institute (CLSI), whilst AmB susceptibility was also determined by Etest. Using a susceptible/resistant MIC cut-off of 1mg/L, all A. fumigatus and A. niger complexes isolates were susceptible to both AmB and AmBisome. In contrast, 38.5% and 30.8% of the A. terreus complex isolates were resistant to AmB and AmBisome, respectively, with good agreement between BMD and Etest methods. With respect to A. flavus complex isolates, 43.7% and 16.7% were resistant by the BMD method to AmBisome and AmB, respectively. For isolates with discrepant results, AmB MICs obtained by Etest were higher than those obtained for AmB by the BMD method and they were closer to those obtained for AmBisome by BMD. Aspergillus flavus AmB MICs ranged from 0.5mg/L to 2mg/L by the BMD method and from 1mg/L to >16mg/L by the Etest method, and AmBisome MICs ranged from 0.06mg/L to >16mg/L by the BMD method. Etest appears to be superior to the CLSI BMD method using AmB in detecting AmB resistance of Aspergillus spp., although the CLSI BMD method might be a suitable procedure if AmBisome is used as the test drug.
    Keywords Aspergillus flavus ; Aspergillus fumigatus ; Aspergillus niger ; Aspergillus terreus ; amphotericin B ; drugs ; minimum inhibitory concentration ; patients
    Language English
    Dates of publication 2012-05
    Size p. 440-443.
    Publishing place Elsevier B.V.
    Document type Article
    ZDB-ID 1093977-5
    ISSN 0924-8579
    ISSN 0924-8579
    DOI 10.1016/j.ijantimicag.2012.01.013
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  10. Article ; Online: The Fourier-transform infrared spectroscopy-based method as a new typing tool for

    De Carolis, Elena / Posteraro, Brunella / Falasca, Benedetta / Spruijtenburg, Bram / Meis, Jacques F / Sanguinetti, Maurizio

    Microbiology spectrum

    2023  , Page(s) e0238823

    Abstract: The Fourier-transform infrared spectroscopy-based IR Biotyper is a straightforward typing tool for bacterial species, but its use ... ...

    Abstract The Fourier-transform infrared spectroscopy-based IR Biotyper is a straightforward typing tool for bacterial species, but its use with
    Language English
    Publishing date 2023-09-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2807133-5
    ISSN 2165-0497 ; 2165-0497
    ISSN (online) 2165-0497
    ISSN 2165-0497
    DOI 10.1128/spectrum.02388-23
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top